Picture of Kainos Laboratories logo

4556 — Kainos Laboratories News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMicro CapNeutral

Table: Kainos -2021/22 parent results

May 9 (Reuters)- 
          Kainos Laboratories Inc 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2022    Mar 31, 2021   Mar 31, 2023     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           4.61            4.26           5.00          2.50    
               (+8.4 pct)      (-7.6 pct)     (+8.3 pct)    (+7.3 pct) 
  Operating      747 mln         632 mln        800 mln      400 mln   
               (+18.3 pct)     (+3.9 pct)     (+7.0 pct)    (-9.5 pct) 
  Recurring      777 mln         653 mln        800 mln      400 mln   
               (+19.0 pct)     (+6.1 pct)     (+2.8 pct)    (-9.9 pct) 
  Net            512 mln         417 mln        520 mln      260 mln   
               (+22.7 pct)     (+4.7 pct)     (+1.5 pct)   (-13.7 pct) 
  EPS          126.39 yen      100.63 yen     128.28 yen    64.14 yen  
  Ann Div       25.00 yen       15.00 yen      25.00 yen               
  -Q2 Div          NIL             NIL            NIL                  
  -Q4 Div       25.00 yen       15.00 yen      25.00 yen               
  
  NOTE - Kainos Laboratories Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4556.T

Recent news on Kainos Laboratories

See all news